Antibiotics are the mainstay prophylaxis and treatment for recurrent urinary tract infections (UTIs). However, antibiotic resistance is rising globally, leading to infections that are harder to treat. In view of this resistance, alternative, non-antibiotic treatments for recurrent UTIs are now being developed; among them, UTI vaccines have shown promising results..

抗生素是复发性尿路感染（UTI）的主要预防和治疗方法。然而，全球抗生素耐药性正在上升，导致感染更难治疗。；其中，UTI疫苗已显示出有希望的结果。。

Access through your institution

通过您的机构访问

Buy or subscribe

购买或订阅

This is a preview of subscription content, access via your institution

这是订阅内容的预览，可通过您的机构访问

Access options

访问选项

Access through your institution

通过您的机构访问

Access through your institution

通过您的机构访问

Change institution

变革机构

Buy or subscribe

购买或订阅

Access Nature and 54 other Nature Portfolio journalsGet Nature+, our best-value online-access subscription24,99 € / 30 dayscancel any timeLearn moreSubscription info for Chinese customersWe have a dedicated website for our Chinese customers. Please go to naturechina.com to subscribe to this journal.Go to naturechina.comBuy this articlePurchase on Springer LinkInstant access to full article PDFBuy nowPrices may be subject to local taxes which are calculated during checkout.

Access Nature和54篇其他Nature Portfolio journalsGet Nature+，我们最有价值的在线订阅24,99欧元/30天，随时为中国客户获取更多订阅信息我们为中国客户提供了一个专门的网站。请访问naturechina.com订阅本期刊。访问naturechina.comBuy本文在Springer link上购买即时访问完整文章PDFBuy now价格可能需要缴纳结帐时计算的地方税。

Additional access options:

其他访问选项：

Log in

登录

Learn about institutional subscriptions

了解机构订阅

Read our FAQs

阅读我们的常见问题

Contact customer support

联系客户支持

ReferencesUnemo, M. et al. World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts. Sex. Health 16, 412–425 (2019).Article

ReferencesUnemo，M。等人。世界卫生组织全球淋球菌抗菌药物监测计划（WHO GASP）：审查新数据和证据，为国际合作行动和研究工作提供信息。性别。健康16412-425（2019）。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Ventola, C. L. The antibiotic resistance crisis: part 1: causes and threats. P T 40, 277–283 (2015).PubMed

Ventola，C.L。抗生素耐药性危机：第1部分：原因和威胁。P T 40277–283（2015）。PubMed出版社

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Ikäheimo, R. et al. Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin. Infect. Dis. 22, 91–99 (1996).Article

Ikäheimo，R.等人。初级保健环境中尿路感染的复发：对179名女性的1年随访分析。临床。感染。Dis。22，91-99（1996）。文章

PubMed

PubMed

Google Scholar

谷歌学者

Sihra, N., Goodman, A., Zakri, R., Sahai, A. & Malde, S. Nonantibiotic prevention and management of recurrent urinary tract infection. Nat. Rev. Urol. 15, 750–776 (2018).Article

Sihra，N.，Goodman，A.，Zakri，R.，Sahai，A。＆Malde，S。非抗生素预防和管理复发性尿路感染。自然修订版Urol。。文章

PubMed

PubMed

Google Scholar

谷歌学者

Benito-Villalvilla, C. et al. MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88. Mucosal Immunol. 10, 924–935 (2017).Article

Benito-Villalvilla，C。等人MV140是一种用于治疗复发性尿路感染的舌下多价细菌制剂，它允许人类树突状细胞通过Syk和MyD88产生Th1，Th17和IL-10反应。。10924-935（2017）。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Carrión-López, P. et al. Cost-effectiveness of a sublingual bacterial vaccine for the prophylaxis of recurrent urinary tract infections. Urol. Int. 106, 730–736 (2022).Article

Carrión-López，P.等人。舌下细菌疫苗预防复发性尿路感染的成本效益。乌洛尔。内景106730-736（2022年）。文章

PubMed

PubMed

Google Scholar

谷歌学者

Kanabar, S., Foley, S. & Yang, B. Assessing the long-term efficacy and safety of MV140 sublingual bacterial vaccine in the initial cohort: a 9-year study in the UK for treating recurrent urinary tract infections in men and women [abstract]. Eur. Urol. 85, S1037 (2024).Article

Kanabar，S.，Foley，S。＆Yang，B。评估MV140舌下细菌疫苗在初始队列中的长期疗效和安全性：英国治疗男性和女性复发性尿路感染的9年研究[摘要]。欧元Urol。85，S1037（2024）。文章

Google Scholar

谷歌学者

Mak, Q., Greig, J., Dasgupta, P., Malde, S. & Raison, N. Bacterial vaccines for the management of recurrent urinary tract infections: a systematic review and meta-analysis. Eur. Urol. Focus https://doi.org/10.1016/j.euf.2024.04.002 (2024).Article

Mak，Q.，Greig，J.，Dasgupta，P.，Malde，S。＆Raison，N。用于治疗复发性尿路感染的细菌疫苗：系统评价和荟萃分析。欧元Urol。焦点https://doi.org/10.1016/j.euf.2024.04.002（2024年）。文章

PubMed

PubMed

Google Scholar

谷歌学者

Perrotta, C., Aznar, M., Mejia, R., Albert, X. & Ng, C. W. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst. Rev. 2, CD005131 (2008).

Perrotta，C.，Aznar，M.，Mejia，R.，Albert，X.＆Ng，C.W。雌激素用于预防绝经后妇女复发性尿路感染。Cochrane数据库系统。第2版，CD005131（2008）。

Google Scholar

谷歌学者

Lorenzo-Gómez, M. F. et al. Comparison of sublingual therapeutic vaccine with antibiotics for the prophylaxis of recurrent urinary tract infections. Front. Cell. Infect. Microbiol. 5, 50 (2015).PubMed

Lorenzo-Gómez，M.F.等人。舌下治疗性疫苗与抗生素预防复发性尿路感染的比较。正面。细胞。感染。微生物。5，50（2015）。PubMed出版社

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Download referencesAuthor informationAuthors and AffiliationsGKT School of Medical Education, King’s College London, London, UKQuentin MakBirmingham Medical School, University of Birmingham, Birmingham, UKJulian GreigDepartment of Urology, Guy’s & St Thomas’ NHS Trust, London, UKProkar Dasgupta & Sachin MaldeSchool of Immunology and Microbial Sciences, King’s College London, Guy’s Hospital, London, UKProkar DasguptaDepartment of Urology, King’s College Hospital NHS Foundation Trust, London, UKNicholas RaisonSchool of Biomedical Engineering and Imaging Sciences, King’s College London, London, UKNicholas RaisonAuthorsQuentin MakView author publicationsYou can also search for this author in.

下载参考文献作者信息作者和附属机构伦敦国王学院医学教育学院，伦敦，伯明翰大学UKQuentin MakBirmingham医学院，伯明翰，UKJulian Greig泌尿科，盖伊和圣托马斯NHS信托基金，伦敦，UKProkar Dasgupta＆Sachin MaldeSchool of Immunology and Microbical Sciences，伦敦国王学院，盖伊医院，伦敦，UKProkar DasguptaDepartment of Urology，国王学院医院NHS Foundation Trust，伦敦，UKNicholas RaisonSchool of Biomedical Engineering and Imaging Sciences，伦敦国王学院，英国尼古拉斯·莱索纳（UkNicholasRaisonAuthorQuentinMakview）作者出版物您也可以在中搜索这位作者。

PubMed Google ScholarJulian GreigView author publicationsYou can also search for this author in

PubMed Google ScholarJulianGreigview作者出版物您也可以在

PubMed Google ScholarProkar DasguptaView author publicationsYou can also search for this author in

PubMed Google ScholarProkar DasguptaView作者出版物您也可以在

PubMed Google ScholarSachin MaldeView author publicationsYou can also search for this author in

PubMed Google ScholarSachin MaldeView作者出版物您也可以在

PubMed Google ScholarNicholas RaisonView author publicationsYou can also search for this author in

PubMed Google ScholarNicholas RaisonView作者出版物您也可以在

PubMed Google ScholarCorresponding authorCorrespondence to

PubMed谷歌学者通讯社

Quentin Mak.Ethics declarations

昆汀·马克。道德宣言

Competing interests

相互竞争的利益

The authors declare no competing interests.

作者声明没有利益冲突。

Rights and permissionsReprints and permissionsAbout this articleCite this articleMak, Q., Greig, J., Dasgupta, P. et al. Promising efficacy of UTI vaccines as an alternative to antibiotics.

权利和许可打印和许可本文引用本文Mak，Q.，Greig，J.，Dasgupta，P。等人。UTI疫苗作为抗生素替代品的有希望的功效。

Nat Rev Urol (2024). https://doi.org/10.1038/s41585-024-00905-8Download citationPublished: 14 June 2024DOI: https://doi.org/10.1038/s41585-024-00905-8Share this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy to clipboard.

Nat Rev Urol（2024年）。https://doi.org/10.1038/s41585-024-00905-8Download引文发布日期：2024年6月14日OI：https://doi.org/10.1038/s41585-024-00905-8Share本文与您共享以下链接的任何人都可以阅读此内容：获取可共享链接对不起，本文目前没有可共享的链接。复制到剪贴板。

Provided by the Springer Nature SharedIt content-sharing initiative

由Springer Nature SharedIt内容共享计划提供